AZD4320, a dual inhibitor of Bcl-2 and Bcl-xL, induces tumor regression in hematological cancer models without dose-limiting thrombocytopenia
Balachander, Srividya B, Criscione, Steven W., Byth, Kate F, Cidado, Justin, Adam, Ammar, MacIntyre, Terry, Wen, Shenghua, Lawson, Deborah, Burke, Kathleen, Lubinski, Tristan J., Tyner, Jeffrey W, KurJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-0863
Date:
September, 2020
File:
PDF, 5.15 MB
2020
File converter
More search results
More benefits 
